Lee's Pharm Announced 2020 Interim Results Positive Profit Alert
HONG KONG, Aug. 14, 2020 /PRNewswire/ -- Lee's Pharmaceutical Holdings Limited ("Lee's Pharm" or the "Group", Stock Code: 950), an integrated research-driven and market-oriented pharmaceutical group inChina, is pleased to announce that it is anticipated that the Group's will record a significant ...
GC Pharma and Lee's Pharm Enter into China Licensing Agreement to Develop and Commercialise GCC-4401C, an Investigational Anticoagulant
YONGIN, South Korea, Feb. 14, 2018 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, and Lee's Pharmaceutical (HK) Limited, a wholly-owned subsidiary of Lee's Pharmaceutical Holdings Limited ("Lee's Pharm") (SEHK: 0950) ...
Lee's Pharm 2015 Interim Profit Attributable to Equity Shareholders Up 18.3%
HONG KONG, Aug. 27, 2015 /PRNewswire/ -- Financial Highlight Six months ended 30 June (HK$'000) Change (%) 2015 2014 Turnover 477,903 442,716 +7.9% Gross Profit 337,829 311,467 +8.5% Profit Attributable to Equity Shareholders 103,026 87,073 +18.3% Basic Earni...
Lee's Pharmaceutical Announces 2013 Third Quarterly Results
Turnover and Net Profit Surged 32.0% and 30.3% Respectively HONG KONG, Nov. 28, 2013 /PRNewswire/ -- Financial Highlight (For the nine months ended 30 September) 2013 2012 Change (HK$'000) (HK$'000) ...
